The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing by Paola Patrignani, Paola Patrignani, Annalisa Contursi, Annalisa Contursi, Stefania Tacconelli, Stefania Tacconelli, Dieter Steinhilber

Connect to this object online.

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies by Patrizia Ballerini, Patrizia Ballerini, Annalisa Contursi, Annalisa Contursi, Annalisa Bruno, Annalisa Bruno, Matteo Mucci, Matteo Mucci, Stefania Tacconelli, Stefania Tacconelli, Paola Patrignani, Paola Patrignani

Connect to this object online.

Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus... by Ulrika Hofling, Ulrika Hofling, Stefania Tacconelli, Stefania Tacconelli, Annalisa Contursi, Annalisa Contursi, Annalisa Bruno, Annalisa Bruno, Matteo Mucci, Matteo Mucci, Patrizia Ballerini, Patrizia Ballerini, Simon Cohen, Paola Patrignani, Paola Patrignani

Connect to this object online.

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action by Paola Patrignani, Paola Patrignani, Stefania Tacconelli, Stefania Tacconelli, Annalisa Contursi, Annalisa Contursi, Elena Piazuelo, Annalisa Bruno, Annalisa Bruno, Stefania Nobili, Stefania Nobili, Matteo Mazzei, Matteo Mazzei, Cristina Milillo, Cristina Milillo, Ulrika Hofling, Ulrika Hofling, Gonzalo Hijos-Mallada, Carlos Sostres, Angel Lanas

Connect to this object online.

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα by Alessandra Ammazzalorso, Stefania Tacconelli, Annalisa Contursi, Ulrika Hofling, Carmen Cerchia, Sara Di Berardino, Alessandra De Michele, Rosa Amoroso, Antonio Lavecchia, Paola Patrignani

Connect to this object online.